Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
May
20
2016
FDA Issues Draft Guidance for Qualified Facilities under the FSMA Preventive Controls Rules Morgan, Lewis & Bockius LLP
Aug
26
2016
New GMO Legislation Signed into Law Morgan, Lewis & Bockius LLP
Oct
12
2016
USDA Releases Updated Guidance on Animal-Raising Claims Morgan, Lewis & Bockius LLP
Jan
10
2017
FDA Issues Final Guidance on Postmarket Cybersecurity Morgan, Lewis & Bockius LLP
Aug
9
2017
FSIS Proposed Nutrition Labeling Rule Placed on Inactive List, Putting National Uniformity at Risk Morgan, Lewis & Bockius LLP
Oct
4
2017
Sequencing Is Coming—FSIS Meeting Will Discuss Intentions Regarding WGS Morgan, Lewis & Bockius LLP
Feb
10
2012
FDA Issues Three Draft Guidances for Biosimilars Morgan, Lewis & Bockius LLP
Feb
5
2018
FDA Doubles Down on Efforts to Develop Guidance for Clinical Trial Stakeholders Morgan, Lewis & Bockius LLP
Dec
2
2013
Federal Energy Regulatory Commission (FERC) Amends Pro Forma Small Generator Interconnection Procedures (SGIP) and Small Generator Interconnection Agreement (SGIA) Morgan, Lewis & Bockius LLP
Feb
11
2014
Temporary Iran Sanctions Relief Morgan, Lewis & Bockius LLP
Apr
8
2014
Health IT Update: Food and Drug Administration Safety and Innovation Act (FDASIA) Health IT Report Issued by FDA, FCC, and ONC Morgan, Lewis & Bockius LLP
Feb
6
2015
Nice Insight on Trends and Expectations for Outsourcing in the Biopharmaceutical Industry Morgan, Lewis & Bockius LLP
Feb
11
2015
European Study Finds Moderate Caffeine Use Safe Morgan, Lewis & Bockius LLP
Mar
10
2015
Bottoms Up: Pennsylvania Liquor Control Board Permits 12-Pack Beer Sales at Beer Distributors Morgan, Lewis & Bockius LLP
Feb
3
2016
No More Genetically Engineered Salmon—In 2016, At Least Morgan, Lewis & Bockius LLP
Feb
25
2016
FDA Highlights Human Factors In Three Recently Issued Guidance Documents Morgan, Lewis & Bockius LLP
Mar
23
2016
Important Developments for Prop 65 Application to BPA Morgan, Lewis & Bockius LLP
Jun
15
2016
FDA Clarifies Policy for Sharing Patient-Specific Data from Devices Morgan, Lewis & Bockius LLP
Jul
13
2016
FSIS Expands Availability of Food Safety Data Online Morgan, Lewis & Bockius LLP
Aug
15
2016
DEA Rejects Petitions Seeking to Reschedule Marijuana Morgan, Lewis & Bockius LLP
Dec
22
2016
FDA Issues Final Guidance on “Emerging Signals” Morgan, Lewis & Bockius LLP
Aug
23
2017
FDA Enters the Menu Labeling Food Fight Morgan, Lewis & Bockius LLP
Oct
24
2017
CFDA Issues New Classification Catalogue for Medical Devices In China Morgan, Lewis & Bockius LLP
Jan
9
2018
Amgen Moves to Dismiss Genentech’s Misrepresentation Claim Morgan, Lewis & Bockius LLP
Sep
4
2013
Federal Energy Regulatory Commission (FERC) Addresses Fuel Obligations of Capacity Resources in ISO New England Morgan, Lewis & Bockius LLP
Dec
6
2013
Federal Energy Regulatory Commission (FERC) Approves Version 5 Critical Infrastructure Protection (CIP) Reliability Standards, Rejects Key Reforms Morgan, Lewis & Bockius LLP
Aug
6
2014
Medical Device Update: FDA Issues Final Guidance on 510(k) Determinations, Use of “Split” Predicates Strongly Discouraged Morgan, Lewis & Bockius LLP
Jul
24
2015
FDA Proposes Rule and Releases Guidance on Third-Party Auditor Program to Expedite Qualified Foreign Food Imports Morgan, Lewis & Bockius LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins